Emerging Medication in Australia: A New Hope for Reducing Body Weight?
Australia is closely watching the arrival of retatrutide, a innovative dual GIP and GLP-1 receptor agonist , representing a exciting advance in obesity treatment . Early study data have demonstrated impressive results, showing greater efficacy than existing treatments like semaglutide. While awai